Left Ventricular Reverse Remodeling In Aortic Valve Replacement With Single Strip Pericardium Versus Mechanical Valve

Sponsor
Fakultas Kedokteran Universitas Indonesia (Other)
Overall Status
Unknown status
CT.gov ID
NCT04056832
Collaborator
(none)
62
1
2
36
1.7

Study Details

Study Description

Brief Summary

Aortic stenosis is a commonly found heart disease, which often leads to mortality and morbidity. Valve replacement using mechanical prosthetic valve will have an expensive cost especially in the Integrated Heart Center of Cipto Mangunkusumo Hospital, Jakarta, Indonesia. In addition to the expensive cost, patients who have mechanical prosthetic valve have an increased risk of infection of the prosthetic valve and developing thrombo-embolism thus have to consume a lifelong anticoagulant therapy that increase risk of bleeding. A surgical technique using autologous pericardium is an alternative to prosthetic valve replacement, one of which is a single pericardium strip technique that uses modified autologous pericardium technique from Ozaki et al and Duran et al.

The objective of this study is to investigate the outcome of aortic valve replacement with a single pericardium strip of autologous pericardium in patients with aortic stenosis.

This study will be conducted at the Integrated Heart Center of Cipto Mangunkusumo Hospital, Jakarta, Indonesia, by using quasi experimental type time series design. Subjects are patients with aortic stenosis who are candidates for valve replacement. Inclusion criteria is having low to moderate surgical risk (EuroScore II <5). The sampling method used in this study is non-probability consecutive sampling. This study will assess the outcome of the aortic valve replacement (valve hemodynamic, left ventricular reverse remodelling, sST2, 6MWT) at 3 months and 6 months post-aortic valve replacement.

It is expected that aortic valve replacement using a single strip of autologous pericardium will have good valve hemodynamic outcome, yield left ventricular reverse remodelling, decrease sST2 level, show upgrade in 6MWT, and have shorter aortic cross clamp time so that it can be an alternative to aortic valve replacement using mechanical prosthetic valve that is less expensive and have good outcomes in patient with aortic stenosis.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Single Strip Pericardium
  • Procedure: Mechanical Prosthetic Valve
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Left Ventricular Reverse Remodeling in Aortic Valve Replacement With Single Strip Pericardium and Mechanical Valve: A Comparative Study
Actual Study Start Date :
Apr 20, 2017
Anticipated Primary Completion Date :
Jan 20, 2020
Anticipated Study Completion Date :
Apr 20, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Single Strip Pericardium

Aortic Valve Replacement using single strip of patient's autologous pericardium

Procedure: Single Strip Pericardium
The anterior pericardium is taken in accordance with the measurements made using an aortic annulus sizer or Ismail sizer. The diameter of the annulus valve is converted to circumference of the aortic valve according as a measure of the length of the pericardium. Measurement of aortic commissure height is done by measuring the distance between the lowest point of the valve attachment to the highest point on the commissure as a measure of pericardium width. The pericardium is immersed in 0.6% glutaraldehyde solution for 10 minutes, then rinsed and soaked with saline solution 3 times for 6 minutes each. After the pericardium becomes firm it is cut to be a single strip according to the length and width in the previous measurement. It is then sutured to the aortic valve annulus.
Other Names:
  • Autologous Pericardium
  • Active Comparator: Mechanical Prosthetic Valve

    Aortic Valve Replacement using mechanical prosthetic valve

    Procedure: Mechanical Prosthetic Valve
    Median incision is performed at the surgical site. Sternal retractor is placed at the sternum after median sternotomy being performed. Aortic valve is measured using aortic annulus sizer. Pledgeted suture is performed for the mattress. Sutures are performed to attach the mechanical prosthetic to the aortic annulus.

    Outcome Measures

    Primary Outcome Measures

    1. Change in Left Ventricular End Diastolic Diameter [before surgery, 3 months and 6 months after surgery]

      Left Ventricular End Diastolic Diameter in mili meters assessed by Trans-thoracic Echocardiography measurement on M-mode

    2. Change in Left Ventricular End Systolic Diameter [before surgery, 3 months and 6 months after surgery]

      Left Ventricular End Systolic Diameter in mili meters assessed by Trans-thoracic Echocardiography measurement on M-mode

    3. Change in Ejection Fraction Percentage [before surgery, 3 months and 6 months after surgery]

      Ejection Fraction Percentage assessed by Trans-thoracic Echocardiography with modified Simpson's volumetric method (BiPlane measurement: apical 4 chambers and apical 2 chambers)

    4. Change in 6 Minute Walking Test Performance (meters) [before surgery, 3 months and 6 months after surgery]

      Subjects will be asked to walk for six minutes on a given track then the distance achieved will be measured in meters

    5. Change in 6 Minute Walking Test Performance (METs) [before surgery, 3 months and 6 months after surgery]

      The result of distance in meters of the six minute walking test will be converted to VO2max by the given formula: (distance in meters x 0.03) + 3.98 = VO2max Then the VO2max will be converted to METs by given formula: VO2max : 3.5 = METs

    6. Change in Soluble Suppression of Tumorigenicity-2 (sST2) Level [before surgery, 3 months and 6 months after surgery]

      Level of soluble Suppression of Tumorigenicity-2 measured in nano gram per mili Liters (ng/mL) by quantitative sandwich enzyme immunoassay technique assessed with Quantikinine Elisa

    Secondary Outcome Measures

    1. Coaptation Height of Aortic Valve Leaflet in mili meters [at the time of surgery]

      Aortic Valve Coaptation height measured in mili meters by Trans-oesophageal Echocardiography on mid-oesophageal long axis view

    2. Effective Height of Aortic Valve in mili meters [at the time of surgery]

      Effective Height of Aortic Valve measured in mili meters from Aortic annulus to the highest point of Aortic Valve coaptation by Trans-oesophageal Echocardiography in mid-oesophageal long axis view

    3. Aortic Jet Velocity Value in m/s [before surgery]

      Aortic Jet Velocity value measured in meters per second (m/s) by Color Wave Doppler on Trans-thoracic Echocardiography

    4. Mean Trans-aortic Pressure Gradient Value in mmHg [before surgery]

      Mean Trans-aortic Pressure Gradient Value measured in mili meters Hydrargyrum (mmHg) with Bernoulli equation on Trans-thoracic Echocardiography

    5. Aortic Stenosis Severity [before surgery]

      Aortic Stenosis Severity classified as mild, moderate, and severe based on Recommendations from European Association of Echocardiography and American Society of Echocardiography (EAE/ASE)

    6. Aortic Regurgitation Severity [before surgery]

      Aortic Regurgitation Severity classified as mild, moderate, and severe based on Recommendations from American Society of Echocardiography

    7. Number of Valve Replacement and/or Repair [at the time of surgery]

      Number of valves being replaced and/or repaired

    8. Aortic Cross Clamp Time in minute [at the time of surgery]

      The time from Aortic Cross Clamp On to Cross Clamp Off

    9. Surgery Time in minute [at the time of surgery]

      The time from first incision to finished closing surgical wound

    10. Cardiopulmonary Bypass Time in minute [at the time of surgery]

      The time from begin Cardiopulmonary Bypass (CPB) On to CPB Off

    11. Duration of Hospitalization [at the time of surgery]

      Number of days of Hospitalization since admission date to discharge date

    Other Outcome Measures

    1. Duration of Intensive Care Unit Stay [at the time of surgery]

      Number of hours in the Intensive Care Unit since after the surgery until subject is transferred to hospital ward

    2. Duration of Ventilator Use [at the time of surgery]

      Number of hours of breathing assisted with ventilator since intubation until extubation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    10 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients aged more than 10 years old

    • Patients with aortic valve stenosis with an indication of aortic valve replacement having low to moderate surgical risk (EuroScore II <5)

    • The patient or guardian (the research subject's parent) agrees to follow the study

    Exclusion Criteria:
    • Patients who have previously underwent aortic valve replacement

    • Patients with aortic stenosis due to bicuspid aortic valve

    • Patients with autoimmune disease

    • Patients with mixed connective tissue disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cipto Mangunkusumo Central National Hospital Jakarta DKI Jakarta Indonesia 10430

    Sponsors and Collaborators

    • Fakultas Kedokteran Universitas Indonesia

    Investigators

    • Principal Investigator: Ismail Dilawar, doctor, Fakultas Kedokteran Universitas Indonesia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Fakultas Kedokteran Universitas Indonesia
    ClinicalTrials.gov Identifier:
    NCT04056832
    Other Study ID Numbers:
    • 011
    • ETIKUI-1612576
    First Posted:
    Aug 14, 2019
    Last Update Posted:
    Aug 14, 2019
    Last Verified:
    Aug 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Fakultas Kedokteran Universitas Indonesia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 14, 2019